RIPK3 and neoplasm: In contrast, in the highly ICI-susceptible model Panc02.OVA, tumor-intrinsic deficiency for RIPK3 was not associated with significant loss of tumor control in C57BL6/J host mice (online supplemental figure S3D–F).